← 返回

实验性小鼠肿瘤模型中再激活记忆 T 细胞 TCR 库的独特特征

英文原题:Unique features of the TCR repertoire of reactivated memory T cells in the experimental mouse tumor model.

查看英文原题

Unique features of the TCR repertoire of reactivated memory T cells in the experimental mouse tumor model.

PubMed 2023/05/26(内容时间) Comput Struct Biotechnol J Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

利用针对肿瘤抗原的T细胞受体(TCR)进行T细胞工程,已成为迈向个性化癌症过继细胞免疫治疗的一项突破。然而,寻找治疗性TCR往往具有挑战性,迫切需要有效策略来识别和富集表达具有优越功能特征TCR的肿瘤特异性T细胞。

我们利用实验性小鼠肿瘤模型,研究了对同种异体肿瘤抗原的初次和二次免疫应答中所涉及T细胞的TCR库特征的连续变化。对TCR库的深入生物信息学分析显示,与初次激活的效应T细胞相比,再激活的记忆T细胞存在差异。在再次遇到同源抗原后,记忆细胞中富集了表达α链TCR的克隆型,这些克隆型具有高潜在交叉反应性,并增强了与MHC及对接肽的相互作用强度。

我们的发现表明,功能上真正的记忆T细胞可能是过继细胞治疗中治疗性TCR的更好来源。在再激活的记忆克隆型中,TCRβ的理化特征未观察到明显变化,这表明TCRα在二次同种异体免疫应答中起主导作用。

本研究结果可进一步促进基于TCR链中心性现象开发TCR修饰的T细胞产品。

展开英文摘要原文

T cell engineering with T cell receptors (TCR) specific to tumor antigens has become a breakthrough towards personalized cancer adoptive cell immunotherapy.

However, the search for therapeutic TCRs is often challenging, and effective strategies are strongly required for the identification and enrichment of tumor-specific T cells that express TCRs with superior functional characteristics. Using an experimental mouse tumor model, we studied sequential changes in TCR repertoire features of T cells involved in the primary and secondary immune responses to allogeneic tumor antigens.

In-depth bioinformatics analysis of TCR repertoires showed differences in reactivated memory T cells compared to primarily activated effectors. After cognate antigen re-encounter, memory cells were enriched with clonotypes that express α-chain TCR with high potential cross-reactivity and enhanced strength of interaction with both MHC and docked peptides.

Our findings suggest that functionally true memory T cells could be a better source of therapeutic TCRs for adoptive cell therapy. No marked changes were observed in the physicochemical characteristics of TCRβ in reactivated memory clonotypes, indicative of the dominant role of TCRα in the secondary allogeneic immune response. The results of this study could further contribute to the development of TCR-modified T cell products based on the phenomenon of TCR chain centricity.

论文信息

作者
Kalinina A、Persiyantseva N、Britanova O、Lupyr K、Shagina I、Khromykh L、Kazansky D
单位
N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Kashirskoe sh. 24, 115478 Moscow, Russian Federation.Russia
期刊
Computational and structural biotechnology journal2023
原文标识
PubMed 37333858 · DOI 10.1016/j.csbj.2023.05.028